D-dimer Levels in Pregnant With COVID-19
Assessment of D-dimer Levels in Pregnant Women Diagnosed With COVID-19
1 other identifier
observational
300
1 country
1
Brief Summary
D-dimer measurements act as a global indicator of coagulation and activation of fibrinolytic systems. An optimal cut-off value for D-dimer and its effect on prognosis has not yet been assessed to predict mortality in admission. Therefore, studies comparing D-dimer values of COVID-19 patients and healthy pregnant women are needed. Our study gives us the opportunity to make this comparison.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2020
CompletedStudy Start
First participant enrolled
May 14, 2020
CompletedFirst Posted
Study publicly available on registry
May 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 29, 2020
CompletedJune 1, 2020
May 1, 2020
14 days
May 14, 2020
May 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare D-dimer values of COVID-19 patients and healthy pregnant women
one day
Study Arms (2)
Control Group
Healthy pregnant women
Study Group
Pregnant women with COVID-19
Interventions
Blood samples will be taken from the patients and will be examined by the ELISA method.
Eligibility Criteria
Kanuni Sultan Suleyman Training and Research Hospital Obstetrics and Gynecology Clinic Patients
You may qualify if:
- Pregnant women with COVID-19
You may not qualify if:
- \- Having a chronic disease that raises D-dimer levels
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Turgut Ozal, Turkey (Türkiye)
Related Publications (1)
Gutierrez Garcia I, Perez Canadas P, Martinez Uriarte J, Garcia Izquierdo O, Angeles Jodar Perez M, Garcia de Guadiana Romualdo L. D-dimer during pregnancy: establishing trimester-specific reference intervals. Scand J Clin Lab Invest. 2018 Oct;78(6):439-442. doi: 10.1080/00365513.2018.1488177. Epub 2018 Jul 5.
PMID: 29975107BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist of Obstetrics and Gynecology
Study Record Dates
First Submitted
May 14, 2020
First Posted
May 15, 2020
Study Start
May 14, 2020
Primary Completion
May 28, 2020
Study Completion
May 29, 2020
Last Updated
June 1, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will share